Glipizide
NDC 52817-385, Glipizide, tablet, from TruPharma LLC.
- Product NDC
- 52817-385
- Status
- Listed
- Labeler
- TruPharma LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214874
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52817-385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE2.5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52817-385-10 | 52817038510 | 100 TABLET in 1 BOTTLE (52817-385-10) |
| 52817-385-50 | 52817038550 | 500 TABLET in 1 BOTTLE (52817-385-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/95ea4c96-84b9-4515-9494-a93d26820f70NADAC price for package 52817038510
GET /v1/drugs/nadac/52817038510
Use it
Look up 52817-385 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52817-385 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52817-385. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.